Jennifer Ali
Nurse Practitioner · Peoria, ILNPI 1992039440
Payments from drug & device makers
Across 658 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Corcept Therapeutics$916
- Boehringer Ingelheim$905
- Pfizer$892
- AbbVie$833
- Abbott$775
- plus $5K from 32 others
What the payments were for
- Food & beverage$10,614100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 71 | $1,090 |
| Corcept Therapeutics | 34 | $916 |
| Boehringer Ingelheim | 49 | $905 |
| Pfizer | 59 | $892 |
| AbbVie | 65 | $833 |
| Abbott | 64 | $775 |
| Amgen | 45 | $577 |
| Novartis | 28 | $459 |
| AstraZeneca | 22 | $418 |
| GSK | 22 | $377 |
| Bayer | 20 | $370 |
| Nestle Healthcare Nutrition Inc. | 29 | $347 |
| Dexcom, Inc. | 18 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $298 |
| Exact Sciences | 13 | $229 |
| Lilly USA, LLC | 13 | $217 |
| Aimmune Therapeutics, Inc. | 14 | $201 |
| Medtronic | 4 | $190 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $163 |
| Merck | 9 | $153 |
| Astellas Pharma US Inc | 7 | $119 |
| Sanofi-aventis U.S. LLC | 6 | $91 |
| Johnson & Johnson | 4 | $90 |
| Biohaven Pharmaceuticals, Inc. | 5 | $81 |
| Insulet Corporation | 4 | $70 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Radius Health, Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Eisai Inc. | 3 | $44 |
| Harmony Biosciences LLC | 2 | $44 |
| Almatica Pharma LLC | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Boston Scientific | 1 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$156
- COREVALVE EVOLUT R$125
How this compares
$10,637 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $100,651 |
| MounjaroTirzepatide | 39 | $68,030 |
| JardianceEmpagliflozin | 54 | $56,210 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $38,999 |
| EliquisApixaban | 21 | $22,123 |
| MyrbetriqMirabegron | 15 | $16,595 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $14,276 |
| Praluent PenAlirocumab | 11 | $12,730 |
| TrulicityDulaglutide | 11 | $12,628 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $11,836 |
| Novolog FlexpenInsulin Aspart | 14 | $6,964 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,003 |
| HumalogInsulin Lispro | 13 | $2,786 |
| Atorvastatin Calcium | 214 | $2,121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $1,664 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,090 | $100,65169 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $217 | $83,44463 claims |
| Boehringer IngelheimJardiance | $905 | $56,21054 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $377 | $53,27557 claims |
| PfizerEliquis | $892 | $22,12321 claims |
| Astellas Pharma US IncMyrbetriq | $119 | $16,59515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Peoria
- Erin WhalenPeoria$34K
- Cally SmithPeoria$26K
- Brynn CinnamonPeoria$17K
- Scott WilsonPeoria$16K
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.